Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TKPHF) Return on Sales (2017 - 2025)

Historic Return on Sales for Takeda Pharmaceutical (TKPHF) over the last 9 years, with Q4 2025 value amounting to 0.14%.

  • Takeda Pharmaceutical's Return on Sales fell 500.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.29%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 0.02% for FY2025, which is 100.0% down from last year.
  • Takeda Pharmaceutical's Return on Sales amounted to 0.14% in Q4 2025, which was down 500.0% from 0.31% recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Return on Sales registered a high of 0.35% during Q1 2025, and its lowest value of 0.07% during Q3 2022.
  • In the last 5 years, Takeda Pharmaceutical's Return on Sales had a median value of 0.19% in 2023 and averaged 0.2%.
  • In the last 5 years, Takeda Pharmaceutical's Return on Sales plummeted by -2200bps in 2022 and then soared by 2700bps in 2025.
  • Takeda Pharmaceutical's Return on Sales (Quarter) stood at 0.1% in 2021, then decreased by -10bps to 0.09% in 2022, then soared by 186bps to 0.25% in 2023, then decreased by -23bps to 0.19% in 2024, then fell by -28bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q4 2025, 0.31% for Q3 2025, and 0.32% during Q2 2025.